Kawasaki, Japan

Tarou Nakamura

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Ea Pharma Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tarou Nakamura. Retrieved from https://idiyas.com/inventor/tarou-nakamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tarou Nakamura

Introduction

Tarou Nakamura is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on sulfonamide derivatives.

Latest Patents

Nakamura holds a patent for a sulfonamide derivative and its medicinal use. This patent describes sulfonamide compounds characterized by a specific chemical structure, where a sulfonamide group is substituted with a phenyl group or a heterocyclic group containing hetero atoms. These compounds are recognized for their excellent α4 integrin-inhibitory action and include pharmaceutically acceptable salts.

Career Highlights

Nakamura is associated with Ea Pharma Co., Ltd., where he has been instrumental in advancing pharmaceutical research. His work has focused on developing novel compounds that can have significant therapeutic applications.

Collaborations

He has collaborated with notable colleagues such as Hirokazu Ueno and Takashi Yamamoto, contributing to a dynamic research environment that fosters innovation.

Conclusion

Tarou Nakamura's contributions to medicinal chemistry through his patented innovations highlight the importance of research in developing new therapeutic agents. His work continues to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…